Biofrontera Inc. (AI10)
Munich
Real-time Data
06:00 AM
Day's Range
0.795052 wk Range
0.7950Overview - AI10 - Biofrontera Inc.
Key Statistics
Valuation
Enterprise Value
12.84M
P/E (Trailing)
‪0.71‬
PEG Ratio
‪-0.0078‬
Price / Sales (TTM)
‪0.25‬
Price / Book
‪2.17‬
EV / EBITDA
‪-2.45‬
Profitability
Gross Margin
‪79.92%‬
Profit Margin
‪-13.78%‬
Operating Margin
‪-4.36%‬
Return on Assets
‪-17.45%‬
Return on Equity
‪-988.35%‬
Ownership
Shares Outstanding
14.20M
Float
11.83M
Held by Insiders
‪11.99%‬
Held by Institutions
‪20.71%‬
Price stats
Beta
‪0.84‬
50-Day Avg
‪0.7950‬
200-Day Avg
‪0.7950‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - AI10 - Biofrontera Inc.
Peers - AI10 - Biofrontera Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Munich.
Profile Summary - AI10 - Biofrontera Inc.
About
Biofrontera Inc. is a U.S.-based biopharmaceutical company focused on dermatology products with an emphasis on photodynamic therapy. Its commercial portfolio centers on Ameluz, a prescription topical gel used together with BF-RhodoLED and RhodoLED lamp systems for the treatment of actinic keratoses, a common…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
